Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis B Kim, Q Tang, PS Biswas, J Xu, RM Schiffelers, FY Xie, AM Ansari, ... The American journal of pathology 165 (6), 2177-2185, 2004 | 364 | 2004 |
Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice PS Biswas, S Gupta, E Chang, L Song, RA Stirzaker, JK Liao, G Bhagat, ... The Journal of clinical investigation 120 (9), 3280-3295, 2010 | 270 | 2010 |
IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor Q Chen, W Yang, S Gupta, P Biswas, P Smith, G Bhagat, AB Pernis Immunity 29 (6), 899-911, 2008 | 219 | 2008 |
Early events in HSV keratitis—setting the stage for a blinding disease PS Biswas, BT Rouse Microbes and infection 7 (4), 799-810, 2005 | 215 | 2005 |
Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin AH Verma, JP Richardson, C Zhou, BM Coleman, DL Moyes, J Ho, ... Science immunology 2 (17), eaam8834, 2017 | 178 | 2017 |
MCPIP1 endoribonuclease activity negatively regulates interleukin-17-mediated signaling and inflammation AV Garg, N Amatya, K Chen, JA Cruz, P Grover, N Whibley, HR Conti, ... Immunity 43 (3), 475-487, 2015 | 150 | 2015 |
Role of neutrophils in IL-17–dependent immunity to mucosal candidiasis AR Huppler, HR Conti, N Hernández-Santos, T Darville, PS Biswas, ... The Journal of Immunology 192 (4), 1745-1752, 2014 | 125 | 2014 |
Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection PS Biswas, K Banerjee, PR Kinchington, BT Rouse Experimental eye research 82 (1), 46-54, 2006 | 115 | 2006 |
Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea K Polcicova, PS Biswas, K Banerjee, TW Wisner, BT Rouse, DC Johnson Proceedings of the National Academy of Sciences 102 (32), 11462-11467, 2005 | 101 | 2005 |
CXCR2−/− mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization K Banerjee, PS Biswas, B Kim, S Lee, BT Rouse The Journal of Immunology 172 (2), 1237-1245, 2004 | 99 | 2004 |
IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis? PS Biswas, G Bhagat, AB Pernis Immunological reviews 233 (1), 79-96, 2010 | 89 | 2010 |
IL-17 metabolically reprograms activated fibroblastic reticular cells for proliferation and survival S Majumder, N Amatya, S Revu, CV Jawale, D Wu, N Rittenhouse, ... Nature immunology 20 (5), 534-545, 2019 | 80 | 2019 |
Dual regulation of IRF4 function in T and B cells is required for the coordination of T–B cell interactions and the prevention of autoimmunity PS Biswas, S Gupta, RA Stirzaker, V Kumar, R Jessberger, TT Lu, ... Journal of Experimental Medicine 209 (3), 581-596, 2012 | 77 | 2012 |
Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis PS Biswas, K Banerjee, B Kim, BT Rouse The Journal of Immunology 172 (6), 3736-3744, 2004 | 75 | 2004 |
Oral epithelial IL-22/STAT3 signaling licenses IL-17–mediated immunity to oral mucosal candidiasis FEY Aggor, TJ Break, G Trevejo-Nuñez, N Whibley, BM Coleman, ... Science immunology 5 (48), eaba0570, 2020 | 72 | 2020 |
Pathogen-specific CD8 T cell responses are directly inhibited by IL-10 PS Biswas, V Pedicord, A Ploss, E Menet, I Leiner, EG Pamer The Journal of Immunology 179 (7), 4520-4528, 2007 | 69 | 2007 |
Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis K Banerjee, PS Biswas, BT Rouse Journal of leukocyte biology 77 (1), 24-32, 2005 | 66 | 2005 |
Herpetic eye disease: immunopathogenesis and therapeutic measures S Deshpande, K Banerjee, PS Biswas, BT Rouse Expert reviews in molecular medicine 6 (8), 1-14, 2004 | 64 | 2004 |
Application of new TOPSIS approach to identify the most significant risk factor and continuous monitoring of death of COVID-19. Electron J Gen Med. 2020; 17 (6): em234 P Majumder, P Biswas, S Majumder Electronic Journal of General Medicine 17, 6, 2020 | 63 | 2020 |
Expression of RXFP1 is decreased in idiopathic pulmonary fibrosis. Implications for relaxin-based therapies J Tan, JR Tedrow, JA Dutta, B Juan-Guardela, M Nouraie, Y Chu, ... American journal of respiratory and critical care medicine 194 (11), 1392-1402, 2016 | 59 | 2016 |